Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

372 ARTÍCULOS , VIENDO DEL 106 AL 120

A 24-week, multicentre, open evaluation of the clinical effectiveness of the rivastigmine patch in patients with probable Alzheimer's disease

Articus K, Baier M, Tracik F, Kühn F, Preuss UW, Kurz A.

Int J Clin Pract. 2011 Jul;65(7):790-6. doi: 10.1111/j.1742-1241.2011.02713.x. Epub 2011 Jun 6.

Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease

Weiner MW, Sadowsky C, Saxton J, Hofbauer RK, Graham SM, Yu SY, Li S, Hsu HA, Suhy J, Fridman M, Perhach JL.

Alzheimers Dement. 2011 Jul;7(4):425-35. doi: 10.1016/j.jalz.2010.09.003. Epub 2011 Jun 8.

Anesthetic modulation of neuroinflammation in Alzheimer's disease

Tang JX, Eckenhoff MF, Eckenhoff RG.

Curr Opin Anaesthesiol. 2011 Aug;24(4):389-94. doi: 10.1097/ACO.0b013e32834871c5.

Carotenoids and Alzheimer's disease: an insight into therapeutic role of retinoids in animal models

Obulesu M, Dowlathabad MR, Bramhachari PV.

Neurochem Int. 2011 Oct;59(5):535-41. doi: 10.1016/j.neuint.2011.04.004. Epub 2011 Jun 7.

Rvx 208

Drugs R D. 2011;11(2):207-13. doi: 10.2165/11595140-000000000-00000.

Combination treatment in Alzheimer's disease: results of a randomized, controlled trial with cerebrolysin and donepezil

Alvarez XA, Cacabelos R, Sampedro C, Couceiro V, Aleixandre M, Vargas M, Linares C, Granizo E, García-Fantini M, Baurecht W, Doppler E, Moessler H.

Curr Alzheimer Res. 2011 Aug;8(5):583-91. doi: 10.2174/156720511796391863.

Red mold fermented products and Alzheimer's disease: a review

Lee CL, Pan TM.

Appl Microbiol Biotechnol. 2011 Aug;91(3):461-9. doi: 10.1007/s00253-011-3413-1. Epub 2011 Jun 18.

New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc

Corona C, Pensalfini A, Frazzini V, Sensi SL.

Cell Death Dis. 2011 Jun 23;2(6):e176. doi: 10.1038/cddis.2011.57.

In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity

da Silva VB, de Andrade P, Kawano DF, Morais PA, de Almeida JR, Carvalho I, Taft CA, da Silva CH.

Future Med Chem. 2011 Jun;3(8):947-60. doi: 10.4155/fmc.11.67.

Effects of galantamine in Alzheimer's disease: double-blind withdrawal studies evaluating sustained versus interrupted treatment

Gaudig M, Richarz U, Han J, Van Baelen B, Schäuble B.

Curr Alzheimer Res. 2011 Nov;8(7):771-80. doi: 10.2174/156720511797633205.

Rivastigmine transdermal patch: a review of its use in the management of dementia of the Alzheimer's type

Dhillon S.

Drugs. 2011 Jun 18;71(9):1209-31. doi: 10.2165/11206380-000000000-00000.

The recent updates of therapeutic approaches against aβ for the treatment of Alzheimer's disease

Ling S, Zhou J, Rudd JA, Hu Z, Fang M.

Anat Rec (Hoboken). 2011 Aug;294(8):1307-18. doi: 10.1002/ar.21425. Epub 2011 Jun 29.

Nuclear receptors as therapeutic targets for Alzheimer's disease

Mandrekar-Colucci S, Landreth GE.

Expert Opin Ther Targets. 2011 Sep;15(9):1085-97. doi: 10.1517/14728222.2011.594043. Epub 2011 Jul 1.

Combination therapy for Alzheimer's disease

Patel L, Grossberg GT.

Drugs Aging. 2011 Jul 1;28(7):539-46. doi: 10.2165/11591860-000000000-00000.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias